Kearns Evan
SEC insider (Form 3/4/5 filer). CIK 0001745285. Chief Legal Officer at Cogent Biosciences, Inc. (COGT). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 26, 2025. Located in WALTHAM, MA.
Companies Kearns Evan has filed insider reports for
- Cogent Biosciences, Inc. (COGT): Officer, Chief Legal Officer
Kearns Evan
CIK: 0001745285
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COGT
Cogent Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 26, 2025COGT
Cogent Biosciences, Inc.
SaleDirect65K shares at avg. $38.70$2.5M - Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect40K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect260K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Tax PaymentDirect125.6K shares at avg. $39.45$5.0M - Jan 23, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
230K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 26, 2025 | COGT Cogent Biosciences, Inc. | Sale | 65,000 | $38.70 | $2,515,500 | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 40,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 260,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Tax Payment | 125,602 | $39.45 | $4,954,999 | Direct |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 230,000 | - | - | Direct |
1-5 of 5 transactions